Focus on Lung Cancer

 

Photo by Cancer Type

“Today’s approvals further illustrate how a greater understanding of the underlying molecular pathways of a disease can lead to the development of targeted treatments.”

FDA Approves New Treatment for a Type of Late-stage Lung Cancer

The U.S. Food and Drug Administration has approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test.

Read More

 

Photo by Cancer Type

Non-Small Cell Lung Cancer

Different types of treat­ments are available for people with non-small cell lung cancer. Surgery, radiation therapy, chemo­therapy, targeted therapy, laser therapy, photodynamic therapy, cryosurgery, electrocautery, and watchful waiting are the nine standard treatments used for this cancer.

Read More

 

Photo by Cancer Type

American Lung Association Resource Offers Lung Cancer Patients and Caregivers

The American Lung Association has launched Facing Lung Cancer: Support from Day One, a new patient- and caregiver-focused, web-based lung cancer information resource. This online tool offers interactive features that address specific topics of interest for people living with lung cancer and their loved ones. 

Read More